Three novel FHL1 variants cause a mild phenotype of Emery-Dreifuss muscular dystrophy.


Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
09 2022
Historique:
revised: 14 04 2022
received: 26 11 2021
accepted: 22 05 2022
pubmed: 25 5 2022
medline: 5 8 2022
entrez: 24 5 2022
Statut: ppublish

Résumé

Emery-Dreifuss muscular dystrophy (EDMD) is a hereditary muscle disease, characterized by the clinical triade of early-onset joint contractures, progressive muscle weakness, and cardiac involvement. Pathogenic variants in FHL1 can cause a rare X-linked recessive form of EDMD, type 6. We report three men with novel variants in FHL1 leading to EDMD6. The onset of muscle symptoms was in late adulthood and muscle weakness was not prominent in either of the patients. All patients had hypertrophic cardiomyopathy and one of them also had cardiac arrhythmias. Western blot performed on muscle biopsies from two of the patients showed no FHL1 protein expression. We predict that the variant in the third patient also leads to the absence of FHL1 protein. Complete loss of all FHL1 isoforms combined with mild muscle involvement supports the hypothesis that loss of all FHL1 isoforms is more benign than the cytotoxic effects of expressed FHL1 protein with pathogenic missense variants.

Identifiants

pubmed: 35607917
doi: 10.1002/humu.24415
pmc: PMC9545859
doi:

Substances chimiques

FHL1 protein, human 0
Intracellular Signaling Peptides and Proteins 0
LIM Domain Proteins 0
Muscle Proteins 0
Protein Isoforms 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1234-1238

Informations de copyright

© 2022 The Authors. Human Mutation published by Wiley Periodicals LLC.

Références

J Neuropathol Exp Neurol. 2013 Sep;72(9):833-45
pubmed: 23965743
BMC Med Genet. 2020 Sep 29;21(1):188
pubmed: 32993534
Am J Hum Genet. 2009 Sep;85(3):338-53
pubmed: 19716112
Neurogenetics. 2013 May;14(2):113-21
pubmed: 23456229
PLoS One. 2011;6(10):e26524
pubmed: 22053194
Hum Mutat. 2022 Sep;43(9):1234-1238
pubmed: 35607917
Clin Genet. 2016 Aug;90(2):171-6
pubmed: 26857240
Eur J Med Genet. 2013 May;56(5):251-5
pubmed: 23500067
Ann Neurol. 2010 Jan;67(1):136-40
pubmed: 20186852
J Cell Mol Med. 2010 Dec;14(12):2702-20
pubmed: 20874719
Eur J Med Genet. 2015 Apr;58(4):222-9
pubmed: 25724586
Semin Pediatr Neurol. 2011 Dec;18(4):257-63
pubmed: 22172421
J Cell Sci. 2014 May 15;127(Pt 10):2269-81
pubmed: 24634512
Nucleus. 2018 Jan 1;9(1):268-274
pubmed: 29633897
Clin Genet. 2016 Aug;90(2):166-70
pubmed: 27409453

Auteurs

Josefine D S Borch (JDS)

Department of Neurology, Rigshospitalet, Copenhagen Neuromuscular Center, University of Copenhagen, Copenhagen, Denmark.

Thomas Krag (T)

Department of Neurology, Rigshospitalet, Copenhagen Neuromuscular Center, University of Copenhagen, Copenhagen, Denmark.

Sonja D Holm-Yildiz (SD)

Department of Neurology, Rigshospitalet, Copenhagen Neuromuscular Center, University of Copenhagen, Copenhagen, Denmark.

Hakan Cetin (H)

Department of Neurology, Medical University of Vienna, Vienna, Austria.

Tuva A Solheim (TA)

Department of Neurology, Rigshospitalet, Copenhagen Neuromuscular Center, University of Copenhagen, Copenhagen, Denmark.

Freja Fornander (F)

Department of Neurology, Rigshospitalet, Copenhagen Neuromuscular Center, University of Copenhagen, Copenhagen, Denmark.

Volker Straub (V)

John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.

Morten Duno (M)

Department of Clinical Genetics, Section 4062, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

John Vissing (J)

Department of Neurology, Rigshospitalet, Copenhagen Neuromuscular Center, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH